-
The Evolving Global Antibody Drug Conjugate (ADC) Technology Market: Growth Prospects, Challenges, and Advancements.
Jun , 25 2024
The rapid growth of the global ADC (Antibody Drug Conjugate) technology market indicates a significant increase in interest and investment in this area of biotherapeutics. ADCs have been recognized as...
read more
-
Advancing ADC Linker and Antibody Conjugation Technology for the Development of Homogenous Antibody Drug Conjugates
Jun , 25 2024
Rising interest in ADC linker and antibody conjugation technology for the development of homogenous antibody drug conjugates (ADCs) is driven by the need for targeted cancer therapies with improved sa...
read more
-
The key factors driving the ADC linker and antibody conjugation technologies market
Jun , 25 2024
The key factors driving the ADC linker and antibody conjugation technologies market can be summarized as follows: Growing Prevalence of Oncological Disorders: Cancer and other oncological disorders ha...
read more
-
Two types of Linkers Utilized in Antibody Drug Conjugates (ADCs): cleavable linkers and non-cleavable linkers.
Jun , 25 2024
In antibody drug conjugates (ADCs), two types of linkers are typically used: cleavable linkers and non-cleavable linkers. Cleavable linkers release the cytotoxic payload near the desired location with...
read more
-
Synthetic Biology Revolutionizing Vitamin Production: Towards Sustainable Development
Aug , 06 2024
Synthetic biology is increasingly becoming a green and efficient alternative in the production of vitamins. Microbial fermentation synthesis, as a key technological approach, avoids the use of toxic c...
read more
-
Semaglutide: Play an important role in Global Weight Loss Market
Sep , 04 2024
Semaglutide, a GLP-1 receptor agonist, is revolutionizing the management of type 2 diabetes and weight loss. It's available in injectable and oral forms, marketed as Ozempic, Rybelsus for diabetes, an...
read more
-
The Globalization Pattern of Innovative Drugs from China
Sep , 04 2024
China has set a new record for the number of its innovative drugs approved in the international market. In 2023 alone, four Chinese-developed drugs received approval from the U.S. Food and Drug Admini...
read more
-
Breakthrough in Synthetic Biology: Enhanced NMN Production in Engineered E. coli
Nov , 13 2024
The collaborative efforts of the synthetic biology and microbial metabolic engineering teams at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, have led to a groundbrea...
read more
-
AMWC 2024: Releases Consensus on Oral Anti-Aging, Leading the New Trend of Oral Beauty
Nov , 15 2024
On October 18, 2024, the AMWC, the World Anti-Aging & Rejuvenation Congress - Oral Anti-Aging Innovation Forum was successfully held in Chengdu. During the conference, the "Expert Consensus on the...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
